Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery

Annals of Thoracic Surgery

Volumn 89, Issue 4, 2010, Pages 1139-1145

  Biancari, Fausto ^a   Myllylä, Mikko ^b   Lepojärvi, Samuli ^a   Kuttila, Kari ^b   Porela, Pekka ^b   Laitio, Timo ^b   Ylitalo, Antti ^c   Jokinen, Vesa ^d   Luokkala, Antti ^d   Airaksinen, K E Juhani ^b,e  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

^d KAINUU CENTRAL HOSPITAL   (Finland)

^e LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; INOTROPIC AGENT; WARFARIN;

ADVERSE OUTCOME; AGED; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REOPERATION; SCORING SYSTEM; STERNOTOMY; STROKE; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; FEMALE; HEMORRHAGE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 77949554100     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.12.072     Document Type: Article

References (19)

1. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
2. Kalavrouziotis D., Buth K.J., Vyas T., and Ali I.S. Preoperative atrial fibrillation decreases event-free survival following cardiac surgery. Eur J Cardiothorac Surg 36 (2009) 293-299
3. Torosian M., Michelson E., Morganroth J., and MacVaugh H. Aspirin- and Coumadin-related bleeding after coronary-artery bypass graft surgery. Ann Intern Med 89 (1978) 325-328
4. Lip G.Y.H., Huber K., Andreotti F., et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. Thromb Haemost 103 (2010) 13-28
5. Annala A., Karjalainen P., Porela P., Nyman K., Ylitalo A., and Airaksinen K. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol 102 (2008) 386-390
6. Karjalainen P., Porela P., Ylitalo A., et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 28 (2007) 726-732
7. Karjalainen P., Vikman S., Niemelä M., et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 29 (2008) 1001-1010
8. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
9. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
10. Charlesworth D.C., Likosky D.S., Marrin C.A., et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 436-443
11. Kangasniemi O.P., Luukkonen J., Biancari F., et al. Risk-scoring methods for prediction of postoperative stroke after coronary artery bypass surgery. J Thorac Cardiovasc Surg 131 (2006) 734-735
12. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 338 (1998) 1488-1497
13. Rogers C.A., Angelini G.D., Culliford L.A., Capoun R., and Ascione R. Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome. Ann Thorac Surg 81 (2006) 1676-1682
14. Surgenor S.D., Kramer R.S., Olmstead E.M., et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108 (2009) 1741-1746
15. Wang T., Robinson L., Ou F., et al. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry. Am Heart J 155 (2008) 361-368
16. Wazni O., Beheiry S., Fahmy T., et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation 116 (2007) 2531-2534
17. Tolosana J.M., Berne P., Mont L., et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin?A prospective randomized trial. Eur Heart J 30 (2009) 1880-1884
18. Lahtela H., Karjalainen P., Niemelä M., et al. Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?. Thromb Haemost 102 (2009) 1227-1233
19. Connolly S., Pogue J., et al., ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367 (2006) 1903-1912